These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4683748)

  • 1. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.
    Giardina EG; Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1973 Feb; 78(2):183-93. PubMed ID: 4683748
    [No Abstract]   [Full Text] [Related]  

  • 2. Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.
    Giardina EG; Bigger JT
    Circulation; 1973 Nov; 48(5):959-70. PubMed ID: 4270892
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic studies of procainamide given intermittently intravenously in patients with severe ventricular arrhytmias.
    Wierzchowiecki M; Jasiński K; Trojanowicz R; Ochotny R; Tomaszkiewicz T
    Cor Vasa; 1978; 20(3):176-83. PubMed ID: 688755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of procainamide and lidocaine on total electrical systole of ventricular premature depolarizations.
    Giardina EG; Bigger JT
    Am J Med; 1975 Sep; 59(3):405-10. PubMed ID: 1163548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of loading dose of procaine amide on left ventricular performance in man.
    Jawad-Kanber G; Sherrod TR
    Chest; 1974 Sep; 66(3):269-72. PubMed ID: 4418506
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.
    Sonnhag C; Karlsson E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):311-7. PubMed ID: 378673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.
    Karlsson E; Kinman A; Sonnhag C
    Eur J Clin Pharmacol; 1977; 11(1):1-6. PubMed ID: 832652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J
    Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M; Campbell RW; Talbot RG; Murray A; Prescott LE; Julian DG
    Adv Clin Pharmacol; 1978; 16():59-70. PubMed ID: 356554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 14. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG; Davis LE; Davis CA
    J Vet Pharmacol Ther; 1986 Dec; 9(4):359-69. PubMed ID: 3806778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procain amide and phenytoin as anti-arrhythmia agents, some dosage principles].
    Karlsson E
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1198-200. PubMed ID: 4839996
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine.
    Miller RR; Hilliard G; Lies JE; Massumi RA; Zelis R; Mason DT; Amsterdam EA
    Am J Med; 1973 Aug; 55(2):161-8. PubMed ID: 4722854
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of procainamide infusions.
    Lima JJ; Goldfarb AL; Conti DR; Golden LH; Bascomb BL; Benedetti GM; Jusko WJ
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of blood tests in procaine amide use (apropos of 188 tests in 36 patients)].
    Chiche P; Benaim R; Lellouch A; Godard JP
    Arch Mal Coeur Vaiss; 1972 Jul; 65(7):797-803. PubMed ID: 4633517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.